| Updating Neuroimmune Targets in Central Nervous System Dysfunction | Trends in Pharmacological Sciences | 13 min | save |  |  |  |  |
| Voltage-gated sodium channels: structures, functions, and molecular modeling | Drug Discovery Today | 1 hour | save | | | | |
| Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study | BMC Clinical Pharmacology | 1 hour | save | | | | |
| Inositol-requiring enzyme 1 alpha endoribonuclease specific inhibitor STF-083010 protects the liver from thioacetamide-induced oxidative stress, inflammation and injury by triggering hepatocyte autophagy. | International Immunopharmacology | 3 hours | save | | | | |
| TLR4 antagonist ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing inflammatory monocytes infiltration in mice model. | International Immunopharmacology | 3 hours | save | | | | |
| A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historian. | Human Vaccines & Immunotherapeutics | 3 hours | save | | | | |
| Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities. | Drugs | 3 hours | save | | | | |
| Tiotropium/Olodaterol: A Review in COPD. | Drugs | 3 hours | save | | | | |
| Crystal Structure of the Monomeric Extracellular Domain ofα9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors. | Frontiers in Pharmacology | 3 hours | save | | | | |
| Evaluation of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Poorly Water-Soluble Talinolol: Preparation, in vitro and in vivo Assessment. | Frontiers in Pharmacology | 3 hours | save | | | | |
| MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies. | Frontiers in Pharmacology | 3 hours | save | | | | |
| Safety and Efficacy of Anti-PD-1 Monoclonal Antibodies in Patients With Relapsed or Refractory Lymphoma: A Meta-Analysis of Prospective Clinic Trails. | Frontiers in Pharmacology | 3 hours | save | | | | |
| NOP-Related Mechanisms in Pain and Analgesia. | Handbook of Experimental Pharmacology | 5 hours | save | | | | |
| Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity. | Handbook of Experimental Pharmacology | 5 hours | save | | | | |
| NOP-Targeted Nonpeptide Ligands. | Handbook of Experimental Pharmacology | 5 hours | save | | | | |
| Genetics and adverse events with irinotecan treatment: what do we know? | Pharmacogenomics | 5 hours | save | | | | |
| Response to“Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project” | Clinical Pharmacology and Therapeutics | 6 hours | save | | | | |
| Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project | Clinical Pharmacology and Therapeutics | 6 hours | save | | | | |
| [ASAP] Sucralose-Enhanced Degradation of Electronic Cigarette Liquids during Vaping | Chemical Research in Toxicology | 8 hours | save | | | | |
| [ASAP] Free-Base Nicotine Is Nearly Absent in Aerosol from IQOS Heat-Not-Burn Devices, As Determined by <sup>1</sup>H NMR Spectroscopy | Chemical Research in Toxicology | 8 hours | save | | | | |
| [ASAP] Influence of in Vitro Assay Setup on the Apparent Cytotoxic Potency of Benzalkonium Chlorides | Chemical Research in Toxicology | 8 hours | save | | | | |
| Entrectinib resistance mechanisms in ROS1 -rearranged non-small cell lung cancer | Investigational New Drugs | 9 hours | save | | | | |
| Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours | Investigational New Drugs | 9 hours | save | | | | |
| Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure–Activity Relationships | Journal of Medicinal Chemistry | 11 hours | save | | | | |
| The Future Is Now: Artificial Intelligence in Drug Discovery | Journal of Medicinal Chemistry | 11 hours | save | | | | |
| Development of Small-Molecules Targeting Receptor Activator of Nuclear Factor-?B Ligand (RANKL)—Receptor Activator of Nuclear Factor-?B (RANK) Protein–Protein Interaction by Structure-Based Virtual Screening and Hit Optimization | Journal of Medicinal Chemistry | 11 hours | save | | | | |
| Antisulfatase, Osteogenic, and Anticancer Activities of Steroid Sulfatase Inhibitor EO-33 in Mice | Journal of Medicinal Chemistry | 11 hours | save | | | | |
| Falcipain Inhibitors Based on the Natural Product Gallinamide A Are Potent in Vitro and in Vivo Antimalarials | Journal of Medicinal Chemistry | 11 hours | save | | | | |
| Structural Tailoring of a Novel Fluorescent IRE-1 RNase Inhibitor to Precisely Control Its Activity | Journal of Medicinal Chemistry | 11 hours | save | | | | |
| Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M<sub>2</sub>R Selectivity | Journal of Medicinal Chemistry | 11 hours | save | | | | |
| Effect of USP Induction Ports, Glass Sampling Apparatus, and Inhaler Device Resistance on Aerodynamic Patterns of Fluticasone Propionate–Loaded Engineered Mannitol Microparticles | AAPS PharmSciTech | 16 hours | save | | | | |
| Reducing Burst Release Effect of Freely Water-Soluble Drug Incorporated into Gastro-Floating Formulation Below HPMC Threshold Concentration Through Interpolymer Complex | AAPS PharmSciTech | 16 hours | save | | | | |
| Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study | BMC Pharmacology and Toxicology | 18 hours | save | | | | |
| The Validation of a Newly Developed Arabic Scale to Assess Patient-Reported Side-Effects of Antineoplastic Agents | Saudi pharmaceutical journal | 22 hours | save | | | | |
| Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets | European Journal of Pharmaceutical Sciences | 23 hours | save | | | | |
| The influence of core tablets rheology on the mechanical properties of press-coated tablets | European Journal of Pharmaceutical Sciences | 23 hours | save | | | | |
| Evaluation of miscibility and polymorphism of synthetic and natural lipids for nanostructured lipid carrier (NLC) formulations by Raman mapping and multivariate curve resolution (MCR) | European Journal of Pharmaceutical Sciences | 23 hours | save | | | | |
| Studying structural and local dynamics in model H-bonded active ingredient — Curcumin in the supercooled and glassy states at various thermodynamic conditions | European Journal of Pharmaceutical Sciences | 23 hours | save | | | | |
| Pharmacokinetics of the SABRE agent 4,6-d2-nicotinamide and also nicotinamide in rats following oral and intravenous administration | European Journal of Pharmaceutical Sciences | 23 hours | save | | | | |
| Cilostazol add-on therapy for celecoxib synergistically inhibits proinflammatory cytokines by activating IL-10 and SOCS3 in the synovial fibroblasts of patients with rheumatoid arthritis | Inflammopharmacology : experimental and clinical studies | 23 hours | save | | | | |
| Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration | Journal of Controlled Release | 23 hours | save | | | | |
| Distinct release strategies are required to modulate macrophage phenotype in young versus aged animals | Journal of Controlled Release | 23 hours | save | | | | |
| Unprecedently high targeting specificity toward lung ICAM-1 using 3DNA nanocarriers | Journal of Controlled Release | 23 hours | save | | | | |
| Enhanced anti-tumor efficacy and safety with metronomic intraperitoneal chemotherapy for metastatic ovarian cancer using biodegradable nanotextile implants | Journal of Controlled Release | 23 hours | save | | | | |
| Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma | Journal of Controlled Release | 23 hours | save | | | | |
| Advances in phenylboronic acid-based closed-loop smart drug delivery system for diabetic therapy | Journal of Controlled Release | 23 hours | save | | | | |
| Loperamide: A Readily Available but Dangerous Opioid Substitute | Journal of Clinical Pharmacology | 1 day | save | | | | |
| An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy | Pharmacology & Therapeutics | 1 day | save | | | | |
| Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies | Pharmacology & Therapeutics | 1 day | save | | | | |
| Tanshinone prevents alveolar bone loss in ovariectomized osteoporosis rats by up-regulating phosphoglycerate dehydrogenase | Toxicology and applied pharmacology | 1 day | save | | | | |
| |  | next » |
| |
